In addition, uptake is rarely linked to an increase in carnitine content in muscular tissue
Most are mild to moderate, but some patients may need to discontinue treatment
Novel GLP-1s are also in development that have much higher high blood brain permeability which may result in different effect profiles
Dose-response relationship of glucagon-like peptide-1 receptor agonists on HbA1c and body weight in type 2 diabetes mellitus: a systematic review and network meta-analysis
Jardine MJ, Hata J, Woodward M, et al
American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 168, 151161.CrossRefGoogle Scholar Heppner, KM, Kirigiti, M, Secher, A, Paulsen, SJ, Buckingham, R, Pyke, C, Knudsen, LB, Vrang, N and Grove, KL (2015) Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain